Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salmeterol/Fluticasone Propionate vs Ipratropium/Albuterol in Chinese Patients With Moderate-to-severe COPD
NCT01243788Phase 4Unknown
- Sponsor
- Fudan University
- Start
- Jul 2009
- Primary completion
- Feb 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of salmeterol, fluticasone propionate in chronic obstructive pulmonary disease (COPD), sponsored by Fudan University. Status: unknown.
02
Drugs
salmeterolfluticasone propionate
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01243788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01243788.